Working to facilitate rapid translation of scientific discoveries into therapeutics

Preliminary Agenda

DAY 1 14 October, 2013
08:00 Onsite Registration
14:00 Conference Opening
Aamir Shahzad, President, European Society for Translational Medicine (EUSTM).
 Welcome Note

  • Anna Chioti, Head of Unit CIEC, Centre de Recherche Public de la Santé (CRP-Santé), Luxembourg.
  • Jean-Claude Schmit, CEO, CRP-Santé, Luxembourg.
14:45 Panel Discussion: Translational Medicine: Current Global State
Potential Benefits
CHAIRS:

  • Anna Chioti, Head of Unit CIEC, Centre de Recherche Public de la Santé (CRP-Santé), Luxembourg.
  • Anna Chioti, Head of Unit CIEC, CRP-Santé, Luxembourg.
  • Cees Winnips, Medical Director Europe, Myriad Genetics, Zürich, Switzerland.
  • Nicholas J. Sarlis, Vice President and Head of Medical Affairs, Incyte Corporation, Wilmington, USA.
  • Enitan Carrol, Institute of Infection & Global Health, University of Liverpool, UK.
15:45 Coffee Break and Visit of Sponsors’ Booths
16:15 SESSION I: Translational Research: Updates in Pathophysiology & DiagnosticsCHAIRS:

  • Daniel Wagner, Head of Cardiovascular Research Laboratory, CRP-Santé, Luxembourg.
  • Wei Wang, Professor, School of Medical Sciences, Edith Cowan University, Australia.

SPEAKERS:

  • Theresa T. Pizarro, Department of Pathology and Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
    Title: ”Emerging role of the IL-33/ST2 axis in gastrointestinal disorders”
  • Enitan Carrol, Institute of Infection & Global Health, University of Liverpool, UK.
    Title: ”A translational journey from Transcriptomics to Novel Diagnostics for infection at the bedside”
  • Ondrej Slaby, Group Leader, Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
    Title: “Translational potential of microRNAs in oncology”
17:15 Inauguration Ceremony: Global Translational Medicine Consortium (GTMC)
(Operated by the EUSTM)
18:00 Cocktail Reception
18:30 Social Program (Optional, for registered participants)
DAY 2 15 October, 2013
08:00 Welcome Coffee Desk & Registration
08:45 SESSION II: Personalized Medicine in Oncology
Chairs:

  • Guy Berchem, CHL & CRP-Santé, Luxembourg.
  • Olga Golubnitschaja, Professor, Department of Radiology, University of Bonn, Germany & European Association for Predictive, Preventive and Personalised Medicine, Belgium.

Speakers:

  • Gottfried Köhler, CEO, OnkoTec GmbH, Max F. Perutz Laboratories, University of Vienna, Austria.
    Title: ”Non-Invasive approach to urinary bladder cancer screening and recurrence”
  • Cees Winnips, Medical Director Europe, Myriad Genetics, Zürich, Switzerland.
    Title: “Translation of an “old” clinical phenomenon in to an innovative treatment for malignant tumor complications: the development history of LTA-T”
  • Godefridus Peters, Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands.
    Title: “Determinants of the efficacy of tyrosine kinase inhibitors: uptake, metabolism and/or the target?”
  • Nicholas J. Sarlis, Vice President and Head of Medical Affairs, Incyte Corporation, Wilmington, USA.
    Title: ”Pitfalls and Solutions in Translational Medicine: Some Examples from Translational Oncology
10:05 Coffee Break and Visit of Sponsors’ Booths
10:45 SESSION III: New Horizons in Biomarkers

  • Chairs:
    Catherine Larue, CEO, Integrated BioBank of Luxembourg.
  • Nicholas J. Sarlis, Vice President and Head of Medical Affairs, Incyte Corporation, Wilmington, USA.

SPEAKERS

  • Ivo Gut, Director, National Genome Analysis Centre (CNAG), Spain.
    Title: “The Genomic and Epigenomic Landscape of Cancer Biomarkers”
  • Philippe Ancian, Senior Director, Vectorology & Biomarkers, Transgene, France.
    Title: ”R&D applications of biomarkers” to “Development of Two Companion Diagnostics (CDx) for a Therapeutic Vaccine for Lung Cancer”
  • Ulrich Pfeffer, Director, National Cancer Research Institute – IST Genova, Italy.
    Title: ”Validation with gene expression data of proposed prostate cancer biomarkers: a long road to travel”
12:25 Lunch and Visit of Sponsors’ Booths
12:25 Press Conference
13:30 SESSION IV: Disease Modelling and EpidemiologyChairs:

  • Michael N. Liebman, Managing Director, Strategic Medicine, Inc, & IPQ Analytics, LLC, USA.
  • Simone Niclou, Head of Norlux Laboratory, CRP-Santé, Luxembourg.

Speakers:

  • Erfan Younesi, Fraunhofer Institute for Algorithms and Scientific Computing SCAI, Department of Bioinformatics, Sankt Augustin, Germany.
    Title: ”Knowledge-based Integrative Disease Modeling in Support of Translational Research”
  • Hugo Geerts, Chief Operating Officer, In-Silico Biosciences, Adj Associate Professor, Perelman School of Medicine, University of Pennsylvania, USA.
    Title: “Using Quantitative Systems Pharmacology for de-risking projects in Alzheimer’s R&D”
  • Michael N. Liebman, Managing Director, Strategic Medicine, Inc, & IPQ Analytics, LLC, USA.
    Title: ”Modeling Disease Processes: From Diagnosis and Staging to Clinical Decision Support”
14:30 Coffee Break and Visit of Sponsors’ Booths
15:00 SESSION V: Public Health and Translational MedicineChairs:

  • Fay Betsou, Chief Biospecimen Science/President of ISBER, IBBL, Luxembourg.
  • Denis Lacombe, Director, EORTC, Belgium.

Speakers:

  • Wei Wang, Professor, School of Medical Sciences, Edith Cowan University, Australia & School of Public Health and Family Medicine, Capital Medical University, Beijing, China.
    Title: ”Suboptimal Health: A Potential Preventive Instrument For Non-Communicable Disease Control and Management”
  • Jes S. Lindholt, Professor, Elitary Research Centre of Individualised Medicine in Arterial Diseases (CIMA) Department of Cardiovascular- and Thoracic Surgery T, University Hospital of Odense, Odense, Denmark.
    Title: ”Beta-blocker Use and Clinical Outcomes after Primary Vascular Surgery: A Nationwide Propensity Score-Matched Study”
  • Olga Golubnitschaja, Professor, Department of Radiology, University of Bonn, Germany & European Association for Predicitive, Preventive and Personalised Medicine, Belgium.
    Title: “The central role of laboratory medicine as the integrating element in healthcare services – global statements of the European Association for Predictive, Preventive and Personalised Medicine”
16:00 SESSION VI: New Horizons in ImmunologyChairs:

  • Fengmin Zhang, Dean, Basic Medical Science School, Harbin Medical University, China.
  • François Hentges, Head of Immunogenetics and Allergology Laboratory, CRP-Santé, Luxembourg.

Speakers:

  • Thomas Stoehr, Head Translational Medicine, Ablynx, Belgium.
    Title: ”Development of an antibody for inhalational therapy of RSV infection in children: design of a strategy to translate from animal studies into first in infant clinical trials”
  • Alexandra Zanin-Zhorov, Senior Director Immunology, Kadmon Research Institute, New York, USA.
    Title: “Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells”
  • Fengmin Zhang, Dean, Basic Medical Science School, Harbin Medical University, China.
    Title: ”The value of decreased plasma gelsolin titers in patients with systemic lupus erythematosus and rheumatic arthritis in diagnosis and disease activity evaluation”
17:00 SESSION VII: EUSTM Expert Panels Showcase SessionChair:

  • Randall J Cohrs, Professor, School of Medicine, University of Colorado, Denver, USA & Vice President, European Society for Translational Medicine (EUSTM).

Speaker:

  • Ernesto Oviedo-Orta, Clinical Sciences Expert, Novartis Vaccines and Diagnostics, Siena, Italy.
    Title: ”Vaccines Development for non noncommunicable diseases-Translational Research Prospectives”
  • Antonio Facchiano, Professor, IDI-IRCCS, Istituto Dermopatico dell’Immacolata, Rome, Italy.
    Title: ”Novel diagnostic approaches to early non-invasive diagnosis: experience on melanoma and tumoral vessel growth”
  • Mauro Magnani, Professor, Department of Biomolecular Sciences, University of Urbino & EryDel SpA, Italy.
    Title: ”Red Blood Cells-mediated delivery of corticosteroid analogues in Ataxia Telangiectasia: clinical studies and mechanism(s) of action”
  • István Jánosi, Managing Director, Planimeter Kft, Budapest Hungary.
    Title: ”Exploration and Description of Ophthalmology Studies Based on ClinicalTrials.gov Database”
18:30 Inauguration Ceremony:The Academy of Translational Medicine
19:00  Cocktail for Conference Participants & Poster Viewing
DAY 3 16 October, 2013
08:00 Welcome Coffee Desk & Registration
08:15 SESSION VIII: Translational Research: Novel FindingsChairs:

  • Yvan Devaux, Associate Head of Cardiovascular Research Laboratory, CRP-Santé, Luxembourg.
  • Ulrich Pfeffer, Director, National Cancer Research Institute – IST Genova, Italy.

Speakers:

  • John T. Weber, School of Pharmacy and Faculty of Medicine, Memorial University of Newfoundland, Canada.
    Title: ”Designing proper experimental approaches to understanding complex neurological disorders.”
  • Denise Sonntag, Director, Contract Research, Biocrates Life Sciences AG, Innsbruck, Austria.
    Title: ”Metabolic Phenotyping in Translational Research”
  • Hüseyin Firat, CEO & President, Firalis SAS, France.
    Title: ”The CardioSAVE project”
09:15 Symposium: Novel developments in the Use of BiomarkersChair:

  • Thomas Stoehr, Head Translational Medicine, Ablynx, Belgium.

Speaker:

  • Guus van Dongen, Professor, Project Leader VU University Medical Imaging Center Amsterdam, The Netherlands.
    Title: “PET imaging with radiolabeled anticancer drugs”
  • Thomas Joos, Director Strategic Alliances EDI GmbH, Myriad RBM Company, Reutlingen, Germany.
    Title: ”Biomarker Patterning using Multi-Analyte Profiles for Applications in Drug Development”
  • Lynn Zieske, VP, Commercial Solutions Singulex, Inc., Alameda, USA.
    Title: “Establishing Clinically Relevant Biomarkers through Advanced Single Molecule Counting Technology”
10:45 Coffee Break and Visit of Sponsors’ Booths
11:15 SESSION  IX: New Horizon in Omics SciencesChairs:

  • Mauro Magnani, Professor, Dipartimento di Scienze Biomolecolari Università degli Studi “Carlo Bo” Urbino, Italy.
  • Gottfried Köhler, CEO, OnkoTec GmbH, Max F. Perutz Laboratories, University of Vienna, Austria.

Speakers:

  • Bruno Domon, Head of LCP, CRP-Santé, Luxembourg.
    Title: “Proteomics in lung cancer”
  • Zhao-Hua Zhong, Associated Director, Department of Microbiology, Harbin Medical University, China.
    Title: ”MiR-342-5p inhibits the infection of coxsackievirus B in vitro through targeting 2C-coding region.”
  • Imad Abugessaisa, Assistant Professor, Unit of Computational Medicine, Center for Molecular Medicine, Department of Medicine Solna, Karolinska Institutet, Sweden.
    Title: ”Implementation of the CDC translational informatics platform-from genetic variants to the national Swedish Rheumatology Quality Register”
12:15 Lunch and Visit of Sponsors’ Booths
13:30 Best Poster Award Ceremony

  • Randall J Cohrs, Professor, School of Medicine, University of Colorado, Denver, USA & Vice President, European Society for Translational Medicine (EUSTM).
14:00 – 15:30 Visionary Closing Panel DiscussionTopics:Practical Steps/Initiatives to achieve benefits from Translational Research, Networking, Consortium, Education & TrainingChairs:

  • Aamir Shahzad, President, European Society for Translational Medicine (EUSTM).
  • Anna Chioti, Head of Unit CIEC (CRP-Santé), Centre de Recherche Public de la Santé, Luxembourg.

Panelist:

  • Thomas Stoehr, Head Translational Medicine, Ablynx, Belgium.
  • Hugo Geerts, Professor, Perelman School of Medicine, Philadelphia, USA.

2013-2019©European Society for Translational Medicine (EUSTM)

Subscribe to Our Newsletter